BSE Live
Jan 21, 10:44Prev. Close
1416.90
Open Price
1408.00
Bid Price (Qty.)
1406.90 (226)
Offer Price (Qty.)
1415.65 (5)
NSE Live
Jan 21, 10:45Prev. Close
1410.30
Open Price
1395.00
Bid Price (Qty.)
1410.20 (5)
Offer Price (Qty.)
1410.90 (1)
| Key Financial Ratios of Hester Biosciences (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 17.14 | 11.86 | 13.44 | 13.74 | 14.63 | |
| Diluted EPS (Rs.) | 17.14 | 11.86 | 13.44 | 13.74 | 14.63 | |
| Cash EPS (Rs.) | 23.36 | 18.18 | 16.56 | 21.01 | 23.26 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 101.13 | 89.31 | 79.79 | 105.89 | 92.44 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 101.13 | 89.31 | 79.79 | 105.89 | 92.44 | |
| Dividend / Share(Rs.) | 3.10 | 2.00 | 2.00 | 1.00 | 3.50 | |
| Revenue from Operations/Share (Rs.) | 105.84 | 81.17 | 76.53 | 85.10 | 80.85 | |
| PBDIT/Share (Rs.) | 31.15 | 30.69 | 26.61 | 33.77 | 35.04 | |
| PBIT/Share (Rs.) | 24.93 | 24.36 | 21.45 | 26.50 | 26.41 | |
| PBT/Share (Rs.) | 22.87 | 16.80 | 17.66 | 21.52 | 21.54 | |
| Net Profit/Share (Rs.) | 17.14 | 11.86 | 11.39 | 13.74 | 14.63 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 29.43 | 37.80 | 34.77 | 39.68 | 43.33 | |
| PBIT Margin (%) | 23.55 | 30.01 | 28.02 | 31.13 | 32.66 | |
| PBT Margin (%) | 21.60 | 20.69 | 23.08 | 25.28 | 26.64 | |
| Net Profit Margin (%) | 16.19 | 14.60 | 14.88 | 16.14 | 18.09 | |
| Return on Networth / Equity (%) | 16.95 | 13.27 | 14.27 | 12.97 | 15.82 | |
| Return on Capital Employed (%) | 13.77 | 11.58 | 12.37 | 12.21 | 14.05 | |
| Return on Assets (%) | 10.36 | 7.83 | 8.44 | 8.47 | 9.29 | |
| Total Debt/Equity (X) | 0.40 | 0.43 | 0.32 | 0.23 | 0.38 | |
| Asset Turnover Ratio (%) | 64.00 | 53.60 | 56.76 | 52.49 | 51.35 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.62 | 1.28 | 1.33 | 1.55 | 1.35 | |
| Quick Ratio (X) | 0.78 | 0.42 | 0.47 | 0.57 | 0.54 | |
| Inventory Turnover Ratio (X) | 3.09 | 1.94 | 2.09 | 1.75 | 1.85 | |
| Dividend Payout Ratio (NP) (%) | 18.08 | 16.86 | 17.55 | 7.27 | 23.91 | |
| Dividend Payout Ratio (CP) (%) | 13.26 | 11.00 | 12.07 | 4.75 | 15.04 | |
| Earnings Retention Ratio (%) | 81.92 | 83.14 | 82.45 | 92.73 | 76.09 | |
| Cash Earnings Retention Ratio (%) | 86.74 | 89.00 | 87.93 | 95.25 | 84.96 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 428.55 | 106.89 | 125.88 | 85.08 | 77.79 | |
| EV/Net Operating Revenue (X) | 4.76 | 1.55 | 1.93 | 1.76 | 1.85 | |
| EV/EBITDA (X) | 16.17 | 4.09 | 5.56 | 4.44 | 4.28 | |
| MarketCap/Net Operating Revenue (X) | 4.42 | 1.09 | 1.62 | 1.50 | 1.44 | |
| Retention Ratios (%) | 81.91 | 83.13 | 82.44 | 92.72 | 76.08 | |
| Price/BV (X) | 4.63 | 0.99 | 1.55 | 1.20 | 1.26 | |
| Price/Net Operating Revenue | 4.42 | 1.09 | 1.62 | 1.50 | 1.44 | |
| Earnings Yield | 0.04 | 0.13 | 0.09 | 0.11 | 0.13 |
19.11.2025
Hester Bio Consolidated September 2025 Net Sales at Rs 70.97 crore, down 15.2% Y-o-Y
18.11.2025
Hester Bio Standalone September 2025 Net Sales at Rs 64.58 crore, down 12.14% Y-o-Y
01.08.2025
Hester Bio Standalone June 2025 Net Sales at Rs 63.49 crore, down 13.58% Y-o-Y
09.05.2025
Hester Bio Standalone March 2025 Net Sales at Rs 76.67 crore, up 5.21% Y-o-Y
19.11.2025
Hester Bio Consolidated September 2025 Net Sales at Rs 70.97 crore, down 15.2% Y-o-Y
18.11.2025
Hester Bio Standalone September 2025 Net Sales at Rs 64.58 crore, down 12.14% Y-o-Y
01.08.2025
Hester Bio Standalone June 2025 Net Sales at Rs 63.49 crore, down 13.58% Y-o-Y
09.05.2025
Hester Bio Standalone March 2025 Net Sales at Rs 76.67 crore, up 5.21% Y-o-Y